AmpliPhi Biosciences (Formerly known as Targeted Genetics)
4870 Sadler Road
Suite 300
Glen Allen
Virginia
23060
United States
Tel: 804-205-5069
Fax: 206-223-0288
Website: http://www.ampliphibio.com/
281 articles about AmpliPhi Biosciences (Formerly known as Targeted Genetics)
-
AmpliPhi Biosciences Announces Positive Interim Results for Single-Patient Expanded Access Program Utilizing AB-SA01 and AB-PA01
1/4/2018
Six of the seven patients (86%) achieved treatment success (physician’s assessment), defined as complete resolution or significant improvement of baseline signs and symptoms.
-
San Diego's AmpliPhi Biosciences Is Reviewing Strategic Alternatives
12/15/2017
AmpliPhi Biosciences announced its progress in 2017 and near-term strategic goals and initiatives.
-
AmpliPhi Biosciences Reports Third Quarter 2017 Financial Results and Business Highlights
11/14/2017
Cash and cash equivalents as of September 30, 2017 totaled $7.7 million.
-
AmpliPhi Biosciences to Hold 2017 Third Quarter and Business Update Conference Call on November 14
11/9/2017
AmpliPhi Biosciences announced that management will hold a business update conference call on Tuesday, November 14, 2017 beginning at 4:30 p.m. Eastern time (1:30 p.m. Pacific time).
-
AmpliPhi Bio Announces Publication Of Preclinical Data For AB-PA01 Showing Activity In Reducing Biofilms Of Pseudomonas Aeruginosa
10/2/2017
-
AmpliPhi Bio’ CEO To Moderate Panel Discussion At Upcoming Anti-Infectives Rx Conference
9/18/2017
-
AmpliPhi Bio Announces First Intravenous Treatment Of A Patient With AB-SA01 Targeting Staphylococcus Aureus
9/11/2017
-
AmpliPhi Bio Announces Receipt Of $2.0 Million R&D Tax Incentive
9/6/2017
-
AmpliPhi Bio Announces Publication Of Bacteriophage Case Study For Life-Threatening Antibiotic-Resistant Infection
8/21/2017
-
AmpliPhi Bio Reports Second Quarter 2017 Financial Results And Business Highlights
8/15/2017
-
AmpliPhi Bio To Hold 2017 Second Quarter And Business Update Conference Call On August 14
8/7/2017
-
AmpliPhi Bio To Present At Bacteriophage Therapy Workshop Sponsored By The FDA And NIH
7/5/2017
-
AmpliPhi Bio Announces Presentation And Panel Participation At BIO International Convention
6/14/2017
-
Effective Immediately: San Diego's AmpliPhi Bio CEO Resigns, New Leader Named
6/1/2017
-
AmpliPhi Bio Reports First Quarter 2017 Financial Results And Provides Business Highlights
5/16/2017
-
AmpliPhi Bio To Hold Business Update Conference Call On May 15
5/11/2017
-
AmpliPhi Bio Announces Closing Of Public Offering
5/11/2017
-
AmpliPhi Bio Announces Pricing Of $10.4 Million Underwritten Public Offering Of Common Stock And Common Warrants
5/5/2017
-
AmpliPhi Bio Announces A New Strategic Emphasis On Personalized Therapies For Serious Or Life-Threatening Antibiotic-Resistant Infections
5/1/2017
-
AmpliPhi Bio Announces Presentation Of Personalized Bacteriophage Therapy Case Study For Life-Threatening Antibiotic-Resistant Infection At Scientific Conference
4/25/2017